Use of ketamine in patients with refractory severe asthma exacerbations: systematic review of prospective studies

[1] Papi A(2018)Asthma Lancet (London, England) 391 783-800

[2] Brightling C(2012)Global asthma prevalence in adults: findings from the cross-sectional world health survey BMC Public Health 12 204-1112

[3] Pedersen SE(2019)The projected economic and health burden of uncontrolled asthma in the United States Am J Respir Crit Care Med 200 1102-2196

[4] Reddel HK(2012)Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 Lancet (London, England) 380 2163-20

[5] To T(2021)Global Initiative for Asthma (GINA) Strategy 2021 - executive summary and rationale for key changes J Allergy Clin Immunol Pract 11 16-52

[6] Stanojevic S(2021)Indacaterol/Glycopyrronium/Mometasone fixed dose combination for uncontrolled asthma Expert Rev Respir Med 119 46-466

[7] Moores G(2020)Molecular targets for biological therapies of severe asthma Front Immunol 19 457-1104

[8] Gershon AS(2017)Point-of-care blood eosinophil count in a severe asthma clinic setting Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 14 1096-35

[9] Bateman ED(2019)Bronchiectasis and asthma: a dangerous liaison? Curr Opin Allergy Clin Immunol 170 29-872

[10] Cruz AA(2021)Comparability of asthma control test scores between self and physician-administered test Uncontrolled asthma: unmet needs in the management of patients 13 865-333

[1] Papi A(2018)Asthma Lancet (London, England) 391 783-800

[2] Brightling C(2012)Global asthma prevalence in adults: findings from the cross-sectional world health survey BMC Public Health 12 204-1112

[3] Pedersen SE(2019)The projected economic and health burden of uncontrolled asthma in the United States Am J Respir Crit Care Med 200 1102-2196

[4] Reddel HK(2012)Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 Lancet (London, England) 380 2163-20

[5] To T(2021)Global Initiative for Asthma (GINA) Strategy 2021 - executive summary and rationale for key changes J Allergy Clin Immunol Pract 11 16-52

[6] Stanojevic S(2021)Indacaterol/Glycopyrronium/Mometasone fixed dose combination for uncontrolled asthma Expert Rev Respir Med 119 46-466

[7] Moores G(2020)Molecular targets for biological therapies of severe asthma Front Immunol 19 457-1104

[8] Gershon AS(2017)Point-of-care blood eosinophil count in a severe asthma clinic setting Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 14 1096-35

[9] Bateman ED(2019)Bronchiectasis and asthma: a dangerous liaison? Curr Opin Allergy Clin Immunol 170 29-872

[10] Cruz AA(2021)Comparability of asthma control test scores between self and physician-administered test Uncontrolled asthma: unmet needs in the management of patients 13 865-333